Login / Signup

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.

Neila SayahDeepak L BhattMichael MillerEliot A BrintonTerry A JacobsonSteven B KetchumLixia JiaoArmando Lira PinedaRalph T DoyleJean Claude TardifChristie M BallantynePhillippe Gabriel Steg
Published in: European heart journal (2024)
Keyphrases
  • acute coronary syndrome
  • phase iii
  • percutaneous coronary intervention
  • study protocol
  • antiplatelet therapy
  • phase ii
  • clinical trial
  • ionic liquid
  • randomized controlled trial
  • open label
  • atrial fibrillation